[Cortical hyperostoses after long-term prostaglandin E2 therapy].
Cortical hyperostoses are found to be side effects after therapy in early infancy with prostaglandin E1 and E2. Correlation seems to exist between dosage and duration of therapy. Radiologically the lesions cannot be differentiated from Caffey's disease. Pathogenetic relationship of the two diseases is discussed; 62 cases of newborn children with ductal related vitium cordis, who were treated for a short time or for longer with prostaglandin E2 are demonstrated.
D015232:Dinoprostone; D005260:Female; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006801:Humans; D006958:Hyperostosis, Cortical, Congenital / Q000139:chemically induced* / Q000000981:diagnostic imaging; D007231:Infant, Newborn; D008297:Male; D011458:Prostaglandins E / Q000008:administration & dosage / Q000009:adverse effects*; D011859:Radiography; D013997:Time Factors
D011458:Prostaglandins E; D015232:Dinoprostone
Kortikale Hyperostosen unter längerfristiger Prostaglandin E2-Therapie.